Biotechnology Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Timo Minssen Vaccines
patent
-
-
Addiction Announcements Chloe Reichel FDA Featured Health Law Policy Informed Consent Insurance Intellectual Property Mason Marks Mental Health Neuroscience Off-Label Use Opioid Crisis Petrie-Flom Center Pharmaceuticals Public Health Race Research Funding Scientific EvidenceQ&A with Mason Marks on New Psychedelics Law and Regulation Initiative
Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative -
Featured Greg Curfman Intellectual Property Judicial Opinions Medical devices Pharmaceuticals Supreme CourtThe Patent Trial and Appeal Board Again Survives Supreme Court Review
Read more: The Patent Trial and Appeal Board Again Survives Supreme Court Review -
Biotechnology Featured Generic Drugs Global Health Health Law Policy Intellectual Property International Jorge Contreras Market Design Pharmaceuticals Public Health Resource Allocation VaccinesUS Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?
Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? -
Biotechnology Featured Health Law Policy Intellectual Property International Pharmaceuticals Public Health Resource Allocation VaccinesThe COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal
Read more: The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal -
The Patent Trial and Appeal Board Returns to the Supreme Court
Read more: The Patent Trial and Appeal Board Returns to the Supreme Court -
Biotechnology Chloe Reichel Featured Health Law Policy Intellectual Property Pharmaceuticals Vaccines4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines
Read more: 4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines -
Clash of Titans? A Brewing Dispute between Telehealth Giants
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants -
Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check -
Biotechnology Featured Health Law Policy Intellectual Property Jorge Contreras Public Health VaccinesDeconstructing Moderna’s COVID-19 Patent Pledge
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge